Home/Pipeline/Pain Therapy Portfolio

Pain Therapy Portfolio

Acute and Chronic Pain

ApprovedActive

Key Facts

Indication
Acute and Chronic Pain
Phase
Approved
Status
Active
Company

About Molteni Farmaceutici

Molteni Farmaceutici is a well-established, privately-held Italian pharmaceutical company with a 130+ year legacy, transitioning from its pharmacy origins to a modern drug developer and manufacturer. Its core business revolves around small molecule therapeutics and medical devices, targeting specific niches such as addiction medicine, pain management, and anesthesia. The company is in a commercial, revenue-generating stage, supported by a portfolio of approved products and a growing international footprint, notably in Poland. Its strategy combines deep therapeutic expertise with a commitment to sustainability and corporate responsibility.

View full company profile

Other Acute and Chronic Pain Drugs

DrugCompanyPhase
KNX101Kinoxis TherapeuticsPreclinical/IND‑enabling
NTM-006NeumentumPhase 2
MAX-001Maxona PharmaceuticalsPhase 2